BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17931708)

  • 1. Treating autoimmune demyelination by augmenting lymphocyte apoptosis in the central nervous system.
    Pender MP
    J Neuroimmunol; 2007 Nov; 191(1-2):26-38. PubMed ID: 17931708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell death during autoimmune demyelination: effector but not target cells are eliminated by apoptosis.
    Bonetti B; Pohl J; Gao YL; Raine CS
    J Immunol; 1997 Dec; 159(11):5733-41. PubMed ID: 9548518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of costimulatory pathways in the pathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitis.
    Chitnis T; Khoury SJ
    J Allergy Clin Immunol; 2003 Nov; 112(5):837-49; quiz 850. PubMed ID: 14610467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of CD8 suppressors versus destructors in autoimmune central nervous system inflammation.
    Zozulya AL; Wiendl H
    Hum Immunol; 2008 Nov; 69(11):797-804. PubMed ID: 18723060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement activation in autoimmune demyelination: dual role in neuroinflammation and neuroprotection.
    Rus H; Cudrici C; Niculescu F; Shin ML
    J Neuroimmunol; 2006 Nov; 180(1-2):9-16. PubMed ID: 16905199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Death ligands and autoimmune demyelination.
    Aktas O; Prozorovski T; Zipp F
    Neuroscientist; 2006 Aug; 12(4):305-16. PubMed ID: 16840707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitor of apoptosis protein (IAP) profiling in experimental autoimmune encephalomyelitis (EAE) implicates increased XIAP in T lymphocytes.
    Moore CS; Hebb AL; Robertson GS
    J Neuroimmunol; 2008 Jan; 193(1-2):94-105. PubMed ID: 18055022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of soluble CD95 are not associated with amelioration of multiple sclerosis during pregnancy.
    Ehrlich S; Haas J; Zipp F; Infante-Duarte C
    J Neurol Sci; 2007 Jan; 252(1):83-7. PubMed ID: 17169375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No life without death.
    Krammer PH; Kamiński M; Kiessling M; Gülow K
    Adv Cancer Res; 2007; 97():111-38. PubMed ID: 17419943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Vogt J; Paul F; Aktas O; Müller-Wielsch K; Dörr J; Dörr S; Bharathi BS; Glumm R; Schmitz C; Steinbusch H; Raine CS; Tsokos M; Nitsch R; Zipp F
    Ann Neurol; 2009 Sep; 66(3):310-22. PubMed ID: 19798635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmunity in the brain: the pathogenesis insight from cell biology.
    Jovanova-Nesic K; Shoenfeld Y
    Ann N Y Acad Sci; 2007 Jun; 1107():142-54. PubMed ID: 17804542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of regulatory T cells in multiple sclerosis.
    Zozulya AL; Wiendl H
    Nat Clin Pract Neurol; 2008 Jul; 4(7):384-98. PubMed ID: 18578001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CNS chemokines, cytokines, and dendritic cells in autoimmune demyelination.
    Segal BM
    J Neurol Sci; 2005 Feb; 228(2):210-4. PubMed ID: 15694210
    [No Abstract]   [Full Text] [Related]  

  • 14. Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system.
    Prinz M; Schmidt H; Mildner A; Knobeloch KP; Hanisch UK; Raasch J; Merkler D; Detje C; Gutcher I; Mages J; Lang R; Martin R; Gold R; Becher B; Brück W; Kalinke U
    Immunity; 2008 May; 28(5):675-86. PubMed ID: 18424188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of T cell apoptosis in nervous system autoimmunity.
    Comi C; Fleetwood T; Dianzani U
    Autoimmun Rev; 2012 Dec; 12(2):150-6. PubMed ID: 22504460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of lymphocyte apoptosis as a strategy for preventing and treating autoimmune disorders: a role for whole-food vegan diets, fish oil and dopamine agonists.
    McCarty MF
    Med Hypotheses; 2001 Aug; 57(2):258-75. PubMed ID: 11461185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibiting leukocyte recruitment to the brain by IVIg: is it relevant to the treatment of demyelinating CNS disorders?
    Dalakas MC
    Brain; 2004 Dec; 127(Pt 12):2569-71. PubMed ID: 15561895
    [No Abstract]   [Full Text] [Related]  

  • 18. Myelin proteolipid protein: an effective autoantigen and target of autoimmunity in multiple sclerosis.
    Greer JM; Pender MP
    J Autoimmun; 2008 Nov; 31(3):281-7. PubMed ID: 18502611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation-induced cell death in T cells and autoimmunity.
    Zhang J; Xu X; Liu Y
    Cell Mol Immunol; 2004 Jun; 1(3):186-92. PubMed ID: 16219166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation and control of pathogenic T cells in OSP/claudin-11-induced EAE in SJL/J mice are dominated by their focused recognition of a single epitopic residue (OSP58M).
    Kaushansky N; Eisenstein M; Oved JH; Ben-Nun A
    Int Immunol; 2008 Nov; 20(11):1439-49. PubMed ID: 18801757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.